Sacramento Area-Based AdvancingBio Launches to Help Patients with Clostridium dIfficile

Over 350,000 Affected in the USSacramento, CA – More than 350,000 cases of Clostridium difficile (C. diff), a dangerous and potentially fatal gastrointestinal bacterial infection, are diagnosed in the United States every year, killing over 15,000 people. AdvancingBio, a not-for-profit organization that offers a treatment to patients suffering from C. diff, announces its launch with the opening of its stool collection and processing facility in Mather, CA, near Sacramento. The facility provides a unique resource for healthcare partners to treat patients with recurrent C. diff using Fecal